Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Targeting Angiogenesis in Colorectal Carcinoma
Anthony Lopez, Kazuto Harada, Maria Vasilakopoulou, et al.
Drugs (2019) Vol. 79, Iss. 1, pp. 63-74
Closed Access | Times Cited: 58

Showing 1-25 of 58 citing articles:

Comprehensive review of targeted therapy for colorectal cancer
Yuanhong Xie, Yingxuan Chen, Jing‐Yuan Fang
Signal Transduction and Targeted Therapy (2020) Vol. 5, Iss. 1
Open Access | Times Cited: 1305
Molecular Mechanisms of Colon Cancer Progression and Metastasis: Recent Insights and Advancements
Ahmed Malki, Rasha Abu ElRuz, Ishita Gupta, et al.
International Journal of Molecular Sciences (2020) Vol. 22, Iss. 1, pp. 130-130
Open Access | Times Cited: 289
Exosomes in Angiogenesis and Anti-angiogenic Therapy in Cancers
Wioletta Olejarz, Grażyna Kubiak-Tomaszewska, Alicja Chrzanowska, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 16, pp. 5840-5840
Open Access | Times Cited: 212
Emerging trends in colorectal cancer: Dysregulated signaling pathways (Review)
Rehan Ahmad, J Singh, Amoolya Wunnava, et al.
International Journal of Molecular Medicine (2021) Vol. 47, Iss. 3
Open Access | Times Cited: 118
Tumor-Associated Neutrophils in Colorectal Cancer Development, Progression and Immunotherapy
Zheng Wei, Jingjing Wu, Yao Peng, et al.
Cancers (2022) Vol. 14, Iss. 19, pp. 4755-4755
Open Access | Times Cited: 51
Molecular mechanisms targeting drug-resistance and metastasis in colorectal cancer: Updates and beyond
Samar Al Bitar, Marwan El‐Sabban, Samer Doughan, et al.
World Journal of Gastroenterology (2023) Vol. 29, Iss. 9, pp. 1395-1426
Open Access | Times Cited: 36
The role of Nrf2 in the pathogenesis and treatment of ulcerative colitis
Shuai Peng, Lei Shen, Xiaoyun Yu, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 35
Identification of novel potent and non-toxic anticancer, anti-angiogenic and antimetastatic rhenium complexes against colorectal carcinoma
Joachim Delasoie, Aleksandar Pavić, Noémie Voutier, et al.
European Journal of Medicinal Chemistry (2020) Vol. 204, pp. 112583-112583
Open Access | Times Cited: 57
Unraveling the complexities of colorectal cancer and its promising therapies – An updated review
Sayan Saha, Shreya Ghosh, Suman Ghosh, et al.
International Immunopharmacology (2024) Vol. 143, pp. 113325-113325
Closed Access | Times Cited: 6
Colorectal Cancer: From Genetic Landscape to Targeted Therapy
Mouade El Bali, Joaira Bakkach, Mohcine Bennani Mechita
Journal of Oncology (2021) Vol. 2021, pp. 1-17
Open Access | Times Cited: 35
Biological factors driving colorectal cancer metastasis
Shuai-Xing An, Zhaojin Yu, Chen Fu, et al.
World Journal of Gastrointestinal Oncology (2024) Vol. 16, Iss. 2, pp. 259-272
Open Access | Times Cited: 5
The Wnt/β-catenin signaling pathway in colorectal cancer: mechanism and intervention of traditional Chinese medicine and chemical compound
Sha Zeng, Juan Wang, Zhengrong Shi, et al.
Frontiers in Pharmacology (2025) Vol. 16
Open Access
Vascular co‐option and vasculogenic mimicry mediate resistance to antiangiogenic strategies
Francesco Pezzella, Doménico Ribatti
Cancer Reports (2020) Vol. 5, Iss. 12
Open Access | Times Cited: 38
Different Forms of Tumor Vascularization and Their Clinical Implications Focusing on Vessel Co-option in Colorectal Cancer Liver Metastases
Gwendolyn Haas, Shuang Fan, Michael Ghadimi, et al.
Frontiers in Cell and Developmental Biology (2021) Vol. 9
Open Access | Times Cited: 27
The pathogenicity of vancomycin-resistant Enterococcus faecalis to colon cancer cells
Li Zhang, Mingxia Deng, Jing Liu, et al.
BMC Infectious Diseases (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 4
A comprehensive view on the fisetin impact on colorectal cancer in animal models: Focusing on cellular and molecular mechanisms
Mohammad Yasin Zamanian, Niloofar Taheri, Montather F. Ramadan, et al.
Animal Models and Experimental Medicine (2024) Vol. 7, Iss. 5, pp. 591-605
Open Access | Times Cited: 4
Molecular mechanism of angiogenesis in colorectal cancer
Portia Raphela-Choma, Mpho Choene, Lesetja R. Motadi
Gene Reports (2025), pp. 102163-102163
Open Access
Chemosensitization of HT29 and HT29-5FU Cell Lines by a Combination of a Multi-Tyrosine Kinase Inhibitor and 5FU Downregulates ABCC1 and Inhibits PIK3CA in Light of Their Importance in Saudi Colorectal Cancer
Ashraf N. Abdalla, Waleed H. Malki, Amal Qattan, et al.
Molecules (2021) Vol. 26, Iss. 2, pp. 334-334
Open Access | Times Cited: 24
Immune-Checkpoint Inhibitors for Metastatic Colorectal Cancer: A Systematic Review of Clinical Outcomes
Dmitrii Shek, L. G. Akhuba, Matteo S. Carlino, et al.
Cancers (2021) Vol. 13, Iss. 17, pp. 4345-4345
Open Access | Times Cited: 22
Neuropeptide Y, a paracrine factor secreted by cancer cells, is an independent regulator of angiogenesis in colon cancer
Debanjan Chakroborty, Sandeep Goswami, Hao Fan, et al.
British Journal of Cancer (2022) Vol. 127, Iss. 8, pp. 1440-1449
Open Access | Times Cited: 15
Inhibition of colorectal cancer tumorigenesis by ursolic acid and doxorubicin is mediated by targeting the Akt signaling pathway and activating the Hippo signaling pathway
Dan Hu, Ruo Yu Meng, Thi Van Nguyen, et al.
Molecular Medicine Reports (2022) Vol. 27, Iss. 1
Open Access | Times Cited: 15
Synthesis and biological evaluation of novel benzylidene-succinimide derivatives as noncytotoxic antiangiogenic inhibitors with anticolorectal cancer activity in vivo
Kaixiu Luo, Yafeng Bao, Feifei Liu, et al.
European Journal of Medicinal Chemistry (2019) Vol. 179, pp. 805-827
Closed Access | Times Cited: 25
Novel human Ab against vascular endothelial growth factor receptor 2 shows therapeutic potential for leukemia and prostate cancer
Ruei‐Min Lu, Chiung‐Yi Chiu, I.-Ju Liu, et al.
Cancer Science (2019) Vol. 110, Iss. 12, pp. 3773-3787
Open Access | Times Cited: 24
Liposomal simvastatin sensitizes C26 murine colon carcinoma to the antitumor effects of liposomal 5‐fluorouracil in vivo
Lavinia Lupuţ, Alina Sesărman, Alina Porfire, et al.
Cancer Science (2020) Vol. 111, Iss. 4, pp. 1344-1356
Open Access | Times Cited: 21
The tumorigenic and therapeutic functions of exosomes in colorectal cancer: Opportunity and challenges
Mahdi Ahmadi, Reza Jafari, Monireh Mahmoodi, et al.
Cell Biochemistry and Function (2021) Vol. 39, Iss. 4, pp. 468-477
Closed Access | Times Cited: 18
Page 1 - Next Page

Scroll to top